Biotech firm Prime Medicine valued at $1.8 bln in strong debut | Reuters

Retrieved on: 2022-10-20 17:43:18

Tags for this article:

Click the tags to see associated articles and topics

Biotech firm Prime Medicine valued at $1.8 bln in strong debut | Reuters. View article details on hiswai:

Excerpt

Biotechnology firm Prime Medicine notched a valuation of about $1.8 billion in its Nasdaq debut on Thursday, braving tough market conditions that ...

Article found on: www.reuters.com